Mad Money' host Jim Cramer looks at several healthcare stocks and shares his perspective on their trajectory in 2025.

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent ...

Stocks in Focus This Week. In this article, we are going to take a look at where U.S. Bancorp (NYSE:USB) stands against the ...

For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during the episode of Mad Money on ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Jim Cramer, the host of Mad Money, recently discussed some of the week’s important market events, focusing on earnings ...

Honeywell International is considering splitting into two companies. Jim Cramer is bullish on the company's plans to break up ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.